250
Participants
Start Date
April 19, 2021
Primary Completion Date
August 31, 2030
Study Completion Date
August 31, 2030
Buprenorphine, Naloxone Drug Combination
8mg of buprenorphine/2mg of naloxone to initiate MOUD treatment and bridge, if necessary, until referral to MOUD clinic can be made for ongoing treatment
Individual Counseling
One-on-one counseling with a licensed chemical dependency counselor
Peer Recovery Support Services
24/7 support from our team of certified peer recovery support specialists to assist with emotional support and case management
Support Group
Referrals to youth-focused support groups and eventual creation of in-house youth-focused support groups
Referral to Medication Management
Study staff will refer patients to long-term MOUD providers in the community
Assertive Outreach
The investigators will conduct weekly outreach to youths who experienced an opioid overdose and attempt to initiate treatment. Outreach is completed by a paramedic and peer coach.
RECRUITING
The University of Texas Health Science Center at Houston, Houston
The University of Texas Health Science Center, Houston
OTHER